Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of octenidine mouthwash concentrations in mild gingivitis
2013-002708-14Phase 2Completed
- Sponsor
- Schülke & Mayr
- Start
- Jul 2013
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of octenidine in gingivitis (4 arms), sponsored by Schülke & Mayr. Primary endpoint: Bacterial count reduction in saliva after single application (V1 and V3). Started Jul 2013; status: completed.
02
Drugs
octenidine
03
Conditions
gingivitis
Beyond the preview
Go deeper on 2013-002708-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002708-14.